Bio-Rad names Rajat Mehta as EVP - Global Commercial Operations
Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics
Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
The company received one observation in the Form-483
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
Shelcal Total marks the brand’s evolution into a modern, consumer-focused nutrition portfolio
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
Subscribe To Our Newsletter & Stay Updated